{"doi":"10.1088/1741-2552/ad171b","title":"NIDCD’s 5-year strategic plan seeks innovations in assistive device technologies","abstract":"NIDCD's 5-year strategic planFor more than 30 years, NIDCD-supported research has spurred critical discoveries leading to increasingly effective, evidence-based treatments for the millions of Americans impacted by conditions affecting taste, smell, hearing, balance, voice, speech, or language.To identify our next priorities, NIDCD developed the 2023-2027 NIDCD Strategic Plan: Advancing the Science of Communication to Improve Lives through iterative collaborations with scientific experts, the NIDCD Advisory Council, NIDCD staff, and the public.The result was a plan describing a unified vision organized around six main priorities: (1) basic research to better understand normal function and disordered processes; (2) model systems to inform research and transform findings into more effective treatments; (3) precision medicine approaches to prevention, diagnosis, and treatment; (4) translation of scientific advances into standard clinical care; (5) biomedical data sharing; and (6) advanced technologies to improve prevention, diagnosis, and treatment [1].To accelerate discoveries in these priority areas, NIDCD encourages investigator-initiated applications to help us better understand the neurological processes underlying disordered communications.We also encourage research focused on improving assistive devices, such as cochlear implants, hearing aids and hearing devices, and brain-computer interfaces (BCIs), that are improving the lives of the millions of Americans impacted by hearing, speech, and other communications disorders [2,3].This article outlines current efforts and opportunities for innovations in these areas. Focus on technological innovations Cochlear and vestibular implantsCollaborations between neuroscientists, engineers, surgeons, and audiologists have significantly improved cochlear implant devices over the last several decades [4], and recent","journal":"Journal of Neural Engineering","year":2023,"id":415162,"datarank":0.0,"base_score":0.0,"endowment":0.0,"self_citation_contribution":0.0,"citation_network_contribution":0.0,"self_endowment_contribution":0.0,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":0,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":0.9544,"is_data_producer":false,"deposit_databanks":null,"is_oa":true,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":"2023-01-01","fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":356380,"name":"Debara L. Tucci","orcid":"0000-0002-9692-6267","position":0,"is_corresponding":true}],"reference_count":16,"raw_metadata":null,"created_at":"2026-07-19T01:22:08.814145Z","pmid":"38113536","pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}